Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

150.03 -1.51 (-1.00%)
Official Closing Price Updated: 7:00 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at branded pharmaceuticals stocks, starting... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:CORT) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
Why Zoetis Stock Took Another Tumble Today
Via The Motley Fool
Why Zoetis Stock Was Falling Today
Via The Motley Fool
Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Zoetis’s shares (currently trading at $166) have posted a disappointing 9.6% loss, well below the S&P 500’s 7.6% gain. This was partly driven by its softer quarterly results... 
Via StockStory
Topics Stocks
Rule Breaker Investing: Pet Perks, Vol. 2
Little things can make a big difference. 
Via The Motley Fool
Discover the top S&P500 movers in Monday's pre-market session.
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now
Via The Motley Fool
Topics Stocks
2 Healthcare Stocks with Big Upside and 1 to Skip
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Zoetis Plunges 9% As 2025 Guidance Misses Expectations
The company topped fourth-quarter expectations, but guidance was no treat. 
Via Investor's Business Daily
Zoetis to Participate in Upcoming Investor Conferences
From Zoetis Inc.
Via Business Wire
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks
Every stock tells a story; it takes humans to find the meaning in it. 
Via The Motley Fool
Love, Money, and Stocks
Via The Motley Fool
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the impact of HPAI on poultry. 
Via Benzinga
What's going on in today's session: S&P500 movers
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. 
Via Chartmill
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
From Zoetis Inc.
Via Business Wire
These S&P500 stocks are gapping in today's session
Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Why Zoetis (ZTS) Shares Are Falling Today
Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported disappointing fourth-quarter results: its full-year EPS and revenue guidance fell short of... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Thursday.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Stocks Rise Despite Hot Producer Inflation, Intel Soars, Bitcoin Drops Below $96,000: What's Driving Markets Thursday?
Wall Street climbed on Thursday, even as the Producer Price Index (PPI) sharply exceeded estimates in January, reigniting concerns over persistent inflationary pressures. 
Via Benzinga
Topics Economy
What's going on in today's session: S&P500 gap up and gap down stocks
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
ZTS earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Zoetis Earnings Top Analysts' Forecasts
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments. 
Via The Motley Fool
Zoetis Drops As 2025 Guidance Falls Short Of Estimates
Zoetis posted Q4 earnings above estimates with strong organic growth. 2025 guidance signals lower-than-expected revenue and EPS, sending shares down. 
Via Benzinga
Which S&P500 stocks are moving before the opening bell on Thursday?
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.